Inhibition of complement alternative pathway function with anti-properdin monoclonal antibodies (Q74128109)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Inhibition of complement alternative pathway function with anti-properdin monoclonal antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

R Gupta-Bansal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J B Parent

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

K R Brunden

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

191-201

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

Complement deficiency. Predisposing factor to autoimmune syndromes

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

A one-step purification method for monoclonal antibodies based on salt-promoted adsorption chromatography on a 'thiophilic' adsorbent

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

The structural requirements for complement activation by IgG: does it hinge on the hinge?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

The electronic aggregometer: a novel device for assessing platelet behavior in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Complement deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

New procedure for the detection of complement deficiency by ELISA. Analysis of activation pathways and circumvention of rheumatoid factor influence.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

1 Preparation of monoclonal antibodies: Strategies and procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Preferential activation and depletion of the alternative complement pathway by burn injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Complement activation during cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

A new enzymatic method to obtain high-yield F(ab)2 suitable for clinical use from mouse IgGl

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Properdin: approaching four decades of research

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Lucigenin-dependent chemiluminescence as a new assay for NAD(P)H-oxidase activity in particulate fractions of human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Complement deficiency and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

C3 proactivator convertase and its mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Early onset of acute pulmonary dysfunction after cardiovascular surgery: risk factors and clinical outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

1 reference

7 January 2021

Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Role of C3 cleavage in monocyte activation during extracorporeal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Profile of complement components in patients with severe burns

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Complement activation and lung permeability during cardiopulmonary bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-5890%2800%2900047-X

7 January 2021

10.1016/S0161-5890(00)00047-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10930626%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference